Cogstate is a brand-new company record, and its full research profile isn't ready yet.
cogstate.comCrawled Oct 25, 2026
Cogstate’s rapid, reliable, and sensitive digital cognitive assessments give clinical trial leaders valuable insight into study outcomes.
Delivering innovative solutions through technology and partnerships to support clinical evaluation and self-assessment of brain health.
Cogstate helps sponsors gather high quality data in Schizophrenia clinical trials via digital cognitive assessments.
Treating schizophrenia involves not only addressing the primary positive and negative symptoms but also the frequent cognitive dysfunction that accompanies the disorder, known as cognitive impairment associated with schizophrenia (CIAS).
This is the first study to demonstrate that elevated lifetime PTSD symptoms are associated with worse cognitive function in a large sample of middle-aged women
In a recent study published in Multiple Sclerosis Journal, researchers compared BICAMS with a set of computerized tests from Cogstate to judge their validity among a pediatric MS cohort.
In a recent paper published in The Clinical Neuropsychologist, researchers investigated the Cogstate Brief Battery’s correlation with traditional neuropsychological tests in a group of breast cancer patients and healthy control volunteers.
Cogstate announced the appointment of Dr. Richard Mohs as a non-executive director.
Cogstate announced the appointment of Jane McAloon as an Independent Non-Executive Director and Chair of the Audit & Compliance Committee of Cogstate Ltd.
Cogstate today announced it has been chosen as the preferred provider to Eli Lilly and Company to support their Alzheimer's disease platform with solutions to ensure high-quality neuropsychological outcome measures in clinical trials.
Cogstate announced today that Richard Gleeson has joined the senior leadership team as Chief Technology Officer, strengthening the company’s ability to deliver transformative innovations to optimize the measurement of cognition in clinical trials and healthcare.
Cogstate offers career opportunities in cognitive measurement and brain health assessment.
Cogstate Research is provided at a discounted rate to scientists and institutions conducting eligible research studies.
Cogstate emphasizes that brain health is essential to quality of life and advocates for easier measurement in clinical trials and practice.
Cogstate integrates cognitive science, operational excellence, and digital innovations to streamline cognitive assessment in clinical research.